1
|
Soffritti I, D'Accolti M, Bini F, Mazziga E, Volta A, Bisi M, Mazzacane S, Caselli E. Probiotic-Based Approaches for Sustainable Control of Infectious Risk in Mass Transport: Current Data and Future Perspectives. Microb Biotechnol 2025; 18:e70177. [PMID: 40515692 PMCID: PMC12166553 DOI: 10.1111/1751-7915.70177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2025] [Revised: 05/23/2025] [Accepted: 05/27/2025] [Indexed: 06/16/2025] Open
Abstract
The built environments of high-traffic areas can play a significant role in the transmission of microorganisms and associated infections, sometimes favouring the selection of multidrug-resistant (MDR) organisms due to the excessive use of conventional disinfectants. Probiotic-based sanitation (PBS) was suggested as a novel alternative approach to control the infectious risk in crowded community environments due to its effectiveness in reducing fungal, bacterial, and viral pathogens in sanitary settings. PBS may thus trigger a paradigm shift from chemical to biological strategies in cleaning environments with high human occupancy, offering an ecological and economically sustainable alternative to conventional chemical disinfection. Providing robust data supporting the results reported so far, it has the potential to optimise bioburden control and infection prevention in mass transportation spaces. This review brings together existing research on PBS in mass transportation areas, pinpoints areas of lack of information, and explores its potential future uses, including the creation of probiotic-based materials for sustainable biocontrol in high-traffic areas.
Collapse
Affiliation(s)
- Irene Soffritti
- Section of Microbiology, Department of Environmental and Prevention SciencesUniversity of FerraraFerraraItaly
- CIAS Research Centre, Tekne‐Hub, University of FerraraFerraraItaly
| | - Maria D'Accolti
- Section of Microbiology, Department of Environmental and Prevention SciencesUniversity of FerraraFerraraItaly
- CIAS Research Centre, Tekne‐Hub, University of FerraraFerraraItaly
| | - Francesca Bini
- Section of Microbiology, Department of Environmental and Prevention SciencesUniversity of FerraraFerraraItaly
- CIAS Research Centre, Tekne‐Hub, University of FerraraFerraraItaly
| | - Eleonora Mazziga
- Section of Microbiology, Department of Environmental and Prevention SciencesUniversity of FerraraFerraraItaly
- CIAS Research Centre, Tekne‐Hub, University of FerraraFerraraItaly
| | - Antonella Volta
- CIAS Research Centre, Tekne‐Hub, University of FerraraFerraraItaly
| | - Matteo Bisi
- CIAS Research Centre, Tekne‐Hub, University of FerraraFerraraItaly
| | - Sante Mazzacane
- CIAS Research Centre, Tekne‐Hub, University of FerraraFerraraItaly
| | - Elisabetta Caselli
- Section of Microbiology, Department of Environmental and Prevention SciencesUniversity of FerraraFerraraItaly
- CIAS Research Centre, Tekne‐Hub, University of FerraraFerraraItaly
| |
Collapse
|
2
|
Odoom A, Tetteh-Quarcoo PB, Donkor ES. Prevalence of Hospital-Acquired Infections in Low- and Middle-Income Countries: Systematic Review and Meta-Analysis. Asia Pac J Public Health 2025:10105395251338002. [PMID: 40401334 DOI: 10.1177/10105395251338002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/23/2025]
Abstract
The burden of hospital-acquired infections (HAIs) is particularly substantial in low- and middle-income countries (LMICs). However, a comprehensive understanding of their prevalence in these regions is lacking. This systematic review aimed to evaluate the prevalence of HAIs in LMICs. Major databases, including Scopus, PubMed, and Web of Science, were thoroughly searched for published studies between January 1, 2000, and July 15, 2024. The PRISMA guidelines were followed. The pooled prevalence of HAIs was estimated using a random-effects model and a 95% confidence interval. The literature search identified 87 studies reporting HAI prevalence in LMICs. The overall prevalence of HAIs across LMICs was 22% (95% CI = [17, 28]). The South-East Asian Region presented the highest prevalence at 37% (95% CI = [13, 62]). In terms of income level, low-income countries had the highest prevalence at 37% (95% CI = [23, 52]). Surgical site infections had the highest prevalence among infection types at 27% (95% CI = [23, 31]). This systematic review underscores the high prevalence of HAIs in most LMICs, emphasizing the need to facilitate the development of targeted prevention and control strategies to mitigate the impact of this critical public health issue, especially in resource-limited settings.
Collapse
Affiliation(s)
- Alex Odoom
- Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana
| | | | - Eric S Donkor
- Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana
| |
Collapse
|
3
|
Bini F, Soffritti I, D'Accolti M, Mazziga E, Caballero JD, David S, Argimon S, Aanensen DM, Volta A, Bisi M, Mazzacane S, Caselli E. Profiling the resistome and virulome of Bacillus strains used for probiotic-based sanitation: a multicenter WGS analysis. BMC Genomics 2025; 26:382. [PMID: 40251489 PMCID: PMC12007294 DOI: 10.1186/s12864-025-11582-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2024] [Accepted: 04/08/2025] [Indexed: 04/20/2025] Open
Abstract
BACKGROUND Healthcare-associated infections (HAIs) caused by microbes that acquire antimicrobial resistance (AMR) represent an increasing threat to human health worldwide. The high use of chemical disinfectants aimed at reducing the presence of pathogens in the hospital environment can simultaneously favor the selection of resistant strains, potentially worsening AMR concerns. In the search for sustainable ways to control bioburden without affecting this aspect, probiotic-based sanitation (PBS) using Bacillus spp. was proposed to achieve stable reduction of pathogens, AMR, and associated HAIs. Although Bacillus probiotics are classified as nonpathogenic, comprehensive data about the potential genetic alterations of these probiotics following prolonged contact with surrounding pathogens are not yet available. This study aimed to assess in depth the genetic content of PBS-Bacillus isolates to evaluate any eventual variations that occurred during their usage. RESULTS WGS analysis was used for the precise identification of PBS-Bacillus species and detailed profiling of their SNPs, resistome, virulome, and mobilome. Analyses were conducted on both the original PBS detergent and 172 environmental isolates from eight hospitals sanitized with PBS over a 30-month period. The two species B. subtilis and B. velezensis were identified in both the original product and the hospital environment, and SNP analysis revealed the presence of two clusters in each species. No virulence/resistance genes or mobile conjugative plasmids were detected in either the original PBS-Bacillus strain or any of the analyzed environmental isolates, confirming their high genetic stability and their low/no tendency to be involved in horizontal gene transfer events. CONCLUSIONS The data obtained by metagenomic analysis revealed the absence of genetic sequences associated with PBS-Bacillus and the lack of alterations in all the environmental isolates analyzed, despite their continuous contact with surrounding pathogens. These results support the safety of the Bacillus species analyzed. Further metagenomic studies aimed at profiling the whole genomes of these and other species of Bacillus, possibly during longer periods and under stress conditions, would be of interest since they may provide further confirmation of their stability and safety.
Collapse
Affiliation(s)
- Francesca Bini
- Section of Microbiology, Department of Environmental and Prevention Sciences, and LTTA, University of Ferrara, Ferrara, 44121, Italy
- CIAS Research Center, University of Ferrara, Ferrara, 44122, Italy
| | - Irene Soffritti
- Section of Microbiology, Department of Environmental and Prevention Sciences, and LTTA, University of Ferrara, Ferrara, 44121, Italy
- CIAS Research Center, University of Ferrara, Ferrara, 44122, Italy
| | - Maria D'Accolti
- Section of Microbiology, Department of Environmental and Prevention Sciences, and LTTA, University of Ferrara, Ferrara, 44121, Italy
- CIAS Research Center, University of Ferrara, Ferrara, 44122, Italy
| | - Eleonora Mazziga
- Section of Microbiology, Department of Environmental and Prevention Sciences, and LTTA, University of Ferrara, Ferrara, 44121, Italy
- CIAS Research Center, University of Ferrara, Ferrara, 44122, Italy
| | - Julio Diaz Caballero
- Centre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK
| | - Sophia David
- Centre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK
| | - Silvia Argimon
- Centre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK
| | - David M Aanensen
- Centre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK
| | - Antonella Volta
- CIAS Research Center, University of Ferrara, Ferrara, 44122, Italy
| | - Matteo Bisi
- CIAS Research Center, University of Ferrara, Ferrara, 44122, Italy
| | - Sante Mazzacane
- CIAS Research Center, University of Ferrara, Ferrara, 44122, Italy
| | - Elisabetta Caselli
- Section of Microbiology, Department of Environmental and Prevention Sciences, and LTTA, University of Ferrara, Ferrara, 44121, Italy.
- CIAS Research Center, University of Ferrara, Ferrara, 44122, Italy.
| |
Collapse
|
4
|
Kochanek M, Berek M, Gibb S, Hermes C, Hilgarth H, Janssens U, Kessel J, Kitz V, Kreutziger J, Krone M, Mager D, Michels G, Möller S, Ochmann T, Scheithauer S, Wagenhäuser I, Weeverink N, Weismann D, Wengenmayer T, Wilkens FM, König V. [S1 guideline on sustainability in intensive care and emergency medicine]. Med Klin Intensivmed Notfmed 2025:10.1007/s00063-025-01261-0. [PMID: 40128386 DOI: 10.1007/s00063-025-01261-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/17/2025] [Indexed: 03/26/2025]
Affiliation(s)
- M Kochanek
- Klinik I für Innere Medizin (Hämatologie und Onkologie), Schwerpunkt Internistische Intensivmedizin, Universitätsklinikum, Centrum für Integrierte Onkologie Aachen Bonn Köln Düsseldorf, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
| | - M Berek
- Klinik für Anästhesiologie, Intensivmedizin und perioperative Schmerztherapie, Städtisches Klinikum Dessau, Dessau-Roßlau, Deutschland
| | - S Gibb
- Universitätsmedizin, Klinik für Anästhesie, Intensiv‑, Notfall- und Schmerzmedizin, Universität Greifswald, Greifswald, Deutschland
| | - C Hermes
- Hochschule für Angewandte Wissenschaften, Hamburg (HAW Hamburg), Alexanderstr. 1, 20099, Hamburg, Deutschland
- Studiengang "Erweiterte Klinische Pflege M.Sc und B.Sc.", Akkon Hochschule für Humanwissenschaften, Berlin, Deutschland
| | - H Hilgarth
- Bundesverband Deutscher Krankenhausapotheker e. V. (ADKA) Berlin, Berlin, Deutschland
| | - U Janssens
- Klinik für Innere Medizin und Internistische Intensivmedizin, St.-Antonius-Hospital, Eschweiler, Deutschland
| | - J Kessel
- Medizinische Klinik 2, Infektiologie, Universitätsklinikum Frankfurt, Goethe-Universität Frankfurt am Main, Theodor Stern Kai 7, Frankfurt am Main, Deutschland
| | - V Kitz
- Interdisziplinäre Intensivstation, Pflegeentwicklung, Agaplesion Diakonieklinikum Hamburg, Hamburg, Deutschland
| | - J Kreutziger
- Univ.-Klinik für Anästhesie und Intensivmedizin, Medizinische Universität Innsbruck, Innsbruck, Österreich
| | - M Krone
- Zentrale Einrichtung Krankenhaushygiene und Antimicrobial Stewardship, Universitätsklinikum Würzburg, Julius-Maximilians-Universität Würzburg, Würzburg, Deutschland
| | - D Mager
- Anästhesiologisch-neurochirurgische Intensivstation 1D, Krankenhaus der Barmherzigen Brüder Trier, Trier, Deutschland
| | - G Michels
- Medizincampus Trier der Universitätsmedizin Mainz, Notfallzentrum, Krankenhaus der Barmherzigen Brüder Trier, Trier, Deutschland
| | - S Möller
- Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Internistische konservative Intensivstation, Universität zu Lübeck, Lübeck, Deutschland
| | - T Ochmann
- Hochschule für Angewandte Wissenschaften, Hamburg (HAW Hamburg), Alexanderstr. 1, 20099, Hamburg, Deutschland
- Klinik für Kardiologie, Internistische Intensivmedizin und Angiologie, Medizinische Intensivstation, Kath. Marienkrankenhaus gGmbH, Hamburg, Deutschland
| | - S Scheithauer
- Institut für Krankenhaushygiene und Infektiologie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen, Göttingen, Deutschland
| | - I Wagenhäuser
- Zentrale Einrichtung Krankenhaushygiene und Antimicrobial Stewardship, Universitätsklinikum Würzburg, Julius-Maximilians-Universität Würzburg, Würzburg, Deutschland
| | - N Weeverink
- Fächerverbund für Infektiologie, Pneumologie und Intensivmedizin, Klinik für Infektiologie und Intensivmedizin, Charité - Universitätsmedizin Berlin, Berlin, Deutschland
| | - D Weismann
- Internistische Notfall- und Intensivmedizin, Medizinische Klinik und Poliklinik I, Universitätsklinikum Würzburg, Julius-Maximilians-Universität Würzburg, Würzburg, Deutschland
| | - T Wengenmayer
- Interdisziplinäre Medizinische Intensivtherapie (IMIT), Universitätsklinikum Freiburg, Medizinische Fakultät, Universität Freiburg, Freiburg, Deutschland
| | - F M Wilkens
- Klinik für Pneumologie und Beatmungsmedizin, Thoraxklinik Heidelberg GmbH, Universitätsklinikum Heidelberg, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Deutschland
| | - V König
- Viszeralmedizinisches und Viszeralonkologisches Zentrum, Interdisziplinäre Intensivstation, Israelitisches Krankenhaus Hamburg, Hamburg, Deutschland
| |
Collapse
|
5
|
Quinn MM, Lindberg JE, Gore RJ, Sama SR, Galligan CJ, Kriebel D, Markkanen PK, LeBouf RF, Virji MA. Respiratory quaternary ammonium and volatile organic compound exposures experienced by home care aides during residential bathroom cleaning using conventional and green products. Ann Work Expo Health 2025; 69:173-190. [PMID: 39657952 PMCID: PMC11858560 DOI: 10.1093/annweh/wxae092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2024] [Accepted: 11/15/2024] [Indexed: 12/12/2024] Open
Abstract
INTRODUCTION US home care (HC) aide visits to clients' homes typically involve cleaning and disinfecting (C&D) environmental surfaces, particularly in bathrooms. Some ingredients in C&D products are associated with respiratory illness: sodium hypochlorite (bleach), quaternary ammonium compounds (QACs), and volatile organic compounds (VOCs). This study assessed and compared aides' respiratory exposures to specific VOCs and QACs while using 2 conventional and 1 "green" household C&D spray products during bathroom cleaning. Measured exposures were compared to ingredients listed on publicly available sources. METHODS Three C&D products were selected with principal active disinfecting ingredients: 1% to 5% sodium hypochlorite by weight ("bleach-based"); 0.1% to 1% QACs ("QACs-based"); and 0.05% thymol ("green"). Twenty-two aides were recruited to perform C&D tasks in a simulated residential bathroom constructed in an environmental monitoring laboratory. A balanced experimental study design involved each aide visiting the lab 4 times to perform typical cleaning tasks with the 3 products and distilled water (as a control), randomly assigned across the 4 visits. Aides wore air sampling equipment for breathing zone samples: canisters to collect whole air for VOC analyses and filter cassettes for QACs analyses. RESULTS Aides performed 84 cleaning visits contributing approximately 20 air samples each for VOCs and QACs, for each of the 3 products and distilled water. In total, 38 unique VOCs were identified in the canister whole air samples: 20 in the QACs-based product samples, 15 in the bleach-based, and 10 in the green. Most VOCs were not listed in publicly available sources of cleaning product ingredients. Toxicity information was limited. Few VOCs had occupational exposure limits. The QACs-based product generated QACs aerosol: benzalkonium chloride (BAC)12 (geometric mean (GM) = 6.98 µg/m3), BAC14 (GM=2.97 µg/m3), BAC16 (GM=0.78 µg/m3); and the 3 QACs summed (GM=10.86 µg/m3). DISCUSSION The use of C&D spray products for residential cleaning can generate respiratory exposures to complex mixtures of volatile and nonvolatile compounds. Notably, we measured aerosols containing QACs during the use of the QACs-based product. Dermal is usually considered the main route of exposure because QACs are nonvolatile salts. This study provides evidence that QACs inhalation exposure should be recognized and minimized in addition to the well-accepted dermal exposure routes. The green product generated the fewest VOCs. However, more toxicity information is needed on the health impacts of green C&D products. Spraying of C&D products, conventional and green, should be avoided. CONCLUSIONS Aides' respiratory health should be protected from chemical exposures while performing C&D in home care.
Collapse
Affiliation(s)
- Margaret M Quinn
- Department of Public Health and Lowell Center for Sustainable Production, University of MassachusettsLowell, 820 Broadway St., Room 203, Lowell, MA, United States
| | - John E Lindberg
- Department of Public Health and Lowell Center for Sustainable Production, University of MassachusettsLowell, 820 Broadway St., Room 203, Lowell, MA, United States
| | - Rebecca J Gore
- Department of Biomedical Engineering, University of MassachusettsLowell, 201 Riverside St., Room 302, Lowell, MA,United States
| | - Susan R Sama
- Department of Public Health and Lowell Center for Sustainable Production, University of MassachusettsLowell, 820 Broadway St., Room 203, Lowell, MA, United States
| | - Catherine J Galligan
- Department of Public Health and Lowell Center for Sustainable Production, University of MassachusettsLowell, 820 Broadway St., Room 203, Lowell, MA, United States
| | - David Kriebel
- Department of Public Health and Lowell Center for Sustainable Production, University of MassachusettsLowell, 820 Broadway St., Room 203, Lowell, MA, United States
| | - Pia K Markkanen
- Department of Public Health and Lowell Center for Sustainable Production, University of MassachusettsLowell, 820 Broadway St., Room 203, Lowell, MA, United States
| | - Ryan F LeBouf
- Division of Respiratory Health, National Institute for Occupational Safety and Health (NIOSH), 1095 Willowdale Road, Morgantown, WV, United States
| | - Mohammed Abbas Virji
- Division of Respiratory Health, National Institute for Occupational Safety and Health (NIOSH), 1095 Willowdale Road, Morgantown, WV, United States
| |
Collapse
|
6
|
Boesenberg D, Brueck C, Chhuon C, Kim J, Miller AJ, Stijntjes GJ, Vedel H, Whiting RC, Van Trump JI. Risk analysis approaches for microbial ingredients in microbial-based cleaning products. RISK ANALYSIS : AN OFFICIAL PUBLICATION OF THE SOCIETY FOR RISK ANALYSIS 2025. [PMID: 39910767 DOI: 10.1111/risa.17707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/01/2024] [Revised: 11/01/2024] [Accepted: 11/14/2024] [Indexed: 02/07/2025]
Abstract
Microbial-based cleaning products (MBCPs) are an emerging class of cleaning products that contain viable microorganisms, often bacteria or bacterial endospores, as intentionally added formulation ingredients for cleaning and/or odor control. Although several well-established methodologies exist to support risk analysis for conventional chemical-based cleaning products, at present there are no widely recognized methods or commonly utilized frameworks to support risk analysis for use of microbial ingredients present in MBCPs, specifically. The purpose of this work is to provide information to MBCP manufacturers and regulators that can be used to assist in developing their own approaches to MBCP risk assessment. As part of this assessment, potential hazards associated with use of bacterial or bacterial endospore ingredients of MBCPs can be adequately characterized, assessed, and managed as part of both product development and ongoing product stewardship. Accordingly, this document summarizes potential approaches to support strain-level identification of microbial ingredient(s), evaluate their hazards and potential for human exposure, and assess their potential effects following such exposures to different human populations. Recommendations for both hazard and risk characterization are discussed. Additionally, guidance is provided to support decision-making by risk managers, including guidance for the development of risk communication strategies, where appropriate, to mitigate the identified risks. Properly applied, the conceptual approaches described herein may facilitate the standardization and more consistent application of appropriate risk analysis procedures tailored to suit microbial ingredients present in MBCPs. Beyond their utility in assessing microbial ingredients commonly used in MBCPs today, these same approaches may help companies and regulators consider and manage risks for new microbial ingredients that may be utilized in future MBCP formulations.
Collapse
Affiliation(s)
| | - Chris Brueck
- Exponent, Inc., Washington, District of Columbia, USA
| | | | - James Kim
- American Cleaning Institute (ACI), Washington, District of Columbia, USA
| | | | | | | | | | | |
Collapse
|
7
|
Timmis K, Karahan ZC, Ramos JL, Koren O, Pérez‐Cobas AE, Steward K, de Lorenzo V, Caselli E, Douglas M, Schwab C, Rivero V, Giraldo R, Garmendia J, Turner RJ, Perlmutter J, Borrero de Acuña JM, Nikel PI, Bonnet J, Sessitsch A, Timmis JK, Pruzzo C, Prieto MA, Isazadeh S, Huang WE, Clarke G, Ercolini D, Häggblom M. Microbes Saving Lives and Reducing Suffering. Microb Biotechnol 2025; 18:e70068. [PMID: 39844583 PMCID: PMC11754571 DOI: 10.1111/1751-7915.70068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2024] [Accepted: 11/25/2024] [Indexed: 01/24/2025] Open
Affiliation(s)
- Kenneth Timmis
- Institute of MicrobiologyTechnical University BraunschweigBraunschweigGermany
| | - Zeynep Ceren Karahan
- Department of Medical Microbiology and Ibn‐i Sina Hospital Central Microbiology LaboratoryAnkara University School of MedicineAnkaraTurkey
| | - Juan Luis Ramos
- Consejo Superior de Investigaciones Científicas, Estación Experimental del ZaidínGranadaSpain
| | - Omry Koren
- Azrieli Faculty of MedicineBar‐Ilan UniversitySafedIsrael
| | - Ana Elena Pérez‐Cobas
- Department of Microbiology, Ramón y Cajal Institute for Health Research (IRYCIS)Ramón y Cajal University HospitalMadridSpain
- CIBER in Infectious Diseases (CIBERINFEC)MadridSpain
| | | | - Victor de Lorenzo
- Department of Systems BiologyNational Centre of Biotechnology CSICMadridSpain
| | - Elisabetta Caselli
- Section of Microbiology, Department of Environmental and Prevention SciencesUniversity of FerraraFerraraItaly
| | - Margaret Douglas
- Usher InstituteUniversity of Edinburgh Medical School, and Public Health ScotlandEdinburghUK
| | - Clarissa Schwab
- Department of Biological and Chemical EngineeringAarhus UniversityAarhusDenmark
| | - Virginia Rivero
- Polymer Biotechnology Lab, Biological Research Center Margarita SalasSpanish National Research Council (CIB‐CSIC)MadridSpain
| | - Rafael Giraldo
- Department of Microbial BiotechnologyNational Centre for Biotechnology (CNB‐CSIC)MadridSpain
| | - Junkal Garmendia
- Instituto de AgrobiotecnologíaConsejo Superior de Investigaciones Científicas (IdAB‐CSIC)‐Gobierno de Navarra, MutilvaMadridSpain
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES)MadridSpain
| | - Raymond J. Turner
- Department of Biological SciencesUniversity of CalgaryCalgaryAlbertaCanada
| | | | | | - Pablo Ivan Nikel
- The Novo Nordisk Foundation Center for BiosustainabilityTechnical University of DenmarkLyngbyDenmark
| | - Jerome Bonnet
- Centre de Biochimie Structurale, INSERM/CNRSUniversity of MontpellierMontpellierFrance
| | - Angela Sessitsch
- Bioresources UnitAIT Austrian Institute of TechnologyViennaAustria
| | - James K. Timmis
- Department of Political ScienceUniversity of FreiburgFreiburgGermany
- Athena Institute for Research on Innovation and Communication in Health and Life SciencesVrije UniversiteitAmsterdamThe Netherlands
| | - Carla Pruzzo
- Department of Earth, Environmental and Life Sciences (DISTAV)University of GenoaGenovaItaly
| | - M. Auxiliadora Prieto
- Polymer Biotechnology Lab, Biological Research Center Margarita SalasSpanish National Research Council (CIB‐CSIC)MadridSpain
| | - Siavash Isazadeh
- Corporate Technical & PerformanceVeolia North AmericaParamusNew JerseyUSA
| | - Wei E. Huang
- Department of Engineering ScienceUniversity of OxfordOxfordUK
| | - Gerard Clarke
- APC Microbiome IrelandUniversity College CorkCorkIreland
- Department of Psychiatry & Neurobehavioral SciencesUniversity College CorkCorkIreland
| | - Danilo Ercolini
- Department of Agricultural SciencesUniversity of Naples Federico IINaplesItaly
| | - Max Häggblom
- Department of Biochemistry and Microbiology, RutgersThe State University of New JerseyNew BrunswickNew JerseyUSA
| |
Collapse
|
8
|
Agyei AA, Amponsah-Tabi S, Dassah ET, Ansong ES, Kankam M, Peprah A, Senaya C, Annan JJK, Reindorff RL, Opare-Addo HS. Factors influencing women's satisfaction with well-woman services at the Manhyia Government Hospital, Ghana. WOMEN'S HEALTH (LONDON, ENGLAND) 2025; 21:17455057251320425. [PMID: 40014686 PMCID: PMC11869239 DOI: 10.1177/17455057251320425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/24/2024] [Revised: 11/14/2024] [Accepted: 01/23/2025] [Indexed: 03/01/2025]
Abstract
INTRODUCTION The provision of well-woman services to women is a very good intervention for promoting good health and well-being among women. Despite data needed to inform increasing accessibility to well-woman services, there is limited information about client's satisfaction with well-woman services. OBJECTIVE This study was conducted to determine factors influencing women's satisfaction with well-woman services at Manhyia Government Hospital. DESIGN An analytical cross-sectional study was conducted among women attending the well-woman clinic at the Manhyia Government Hospital, Kumasi from 10 May 2023 to 15 November 2023. METHODS A systematic sampling method was employed. A pretested structured questionnaire was used to collect data on participants' socio-demographic and clinical characteristics, health-facility-related factors, barriers to utilization and client satisfaction. A face-to-face interview was conducted for every woman included in the study. Data were analyzed using multivariable logistic regression analysis. p-Value for statistical significance was set at p < 0.05. RESULTS Of the 344 women who were recruited for the study, majority (65.7%) of them were satisfied with care at the well-woman clinic. About 59.3% of the women were willing to continue care at the clinic. The age range was 18-60 with mean of 34.6 ± 12.0 years. Some of the challenges the women reported in accessing well-woman services at the clinic included long waiting times (17.7%) and inadequately skilled staff (8.1%). After adjusting for significant variables in the multivariable logistic regression analysis (adjusted odds ratio (AOR)), comfortability of the waiting area (AOR: 7.71, 95% CI: 1.54-38.60), <6 months duration of accessing care (AOR: 8.82, 95% CI: 3.25-23.98) and friendly attitude of health workers (AOR: 27.03, 95% CI: 4.28-170.83) were significantly associated with the client's satisfaction with well-woman services. CONCLUSION There was high satisfaction with well-woman services at the clinic, and this was associated with factors such as duration of service, comfortability of the waiting area and the attitude of health workers. Training more skilled staff and expanding the clinic will help improve well-woman services.
Collapse
Affiliation(s)
| | - Seth Amponsah-Tabi
- Department of Obstetrics and Gynaecology, Suntreso Government Hospital, Ashanti, Ghana
- Saint Patrick’s Hospital, Offinso Municipal Area, Ashanti, Ghana
| | - Edward Tieru Dassah
- School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- Directorate of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Ashanti, Ghana
| | | | - Maxwell Kankam
- Saint Patrick’s Hospital, Offinso Municipal Area, Ashanti, Ghana
| | - Amponsah Peprah
- Department of Obstetrics and Gynaecology, School of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- Directorate of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Ashanti, Ghana
| | - Charles Senaya
- Directorate of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Ashanti, Ghana
| | - John Jude Kweku Annan
- Department of Obstetrics and Gynaecology, School of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- Directorate of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Ashanti, Ghana
| | - Roderick Larsen Reindorff
- Department of Obstetrics and Gynaecology, School of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- Directorate of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Ashanti, Ghana
| | - Henry S Opare-Addo
- Department of Obstetrics and Gynaecology, School of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- Directorate of Obstetrics and Gynaecology, Komfo Anokye Teaching Hospital, Ashanti, Ghana
| |
Collapse
|
9
|
Kramer A, Lexow F, Bludau A, Köster AM, Misailovski M, Seifert U, Eggers M, Rutala W, Dancer SJ, Scheithauer S. How long do bacteria, fungi, protozoa, and viruses retain their replication capacity on inanimate surfaces? A systematic review examining environmental resilience versus healthcare-associated infection risk by "fomite-borne risk assessment". Clin Microbiol Rev 2024; 37:e0018623. [PMID: 39388143 PMCID: PMC11640306 DOI: 10.1128/cmr.00186-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2024] Open
Abstract
SUMMARYIn healthcare settings, contaminated surfaces play an important role in the transmission of nosocomial pathogens potentially resulting in healthcare-associated infections (HAI). Pathogens can be transmitted directly from frequent hand-touch surfaces close to patients or indirectly by staff and visitors. HAI risk depends on exposure, extent of contamination, infectious dose (ID), virulence, hygiene practices, and patient vulnerability. This review attempts to close a gap in previous reviews on persistence/tenacity by only including articles (n = 171) providing quantitative data on re-cultivable pathogens from fomites for a better translation into clinical settings. We have therefore introduced the new term "replication capacity" (RC). The RC is affected by the degree of contamination, surface material, temperature, relative humidity, protein load, organic soil, UV-light (sunlight) exposure, and pH value. In general, investigations into surface RC are mainly performed in vitro using reference strains with high inocula. In vitro data from studies on 14 Gram-positive, 26 Gram-negative bacteria, 18 fungi, 4 protozoa, and 37 viruses. It should be regarded as a worst-case scenario indicating the upper bounds of risks when using such data for clinical decision-making. Information on RC after surface contamination could be seen as an opportunity to choose the most appropriate infection prevention and control (IPC) strategies. To help with decision-making, pathogens characterized by an increased nosocomial risk for transmission from inanimate surfaces ("fomite-borne") are presented and discussed in this systematic review. Thus, the review offers a theoretical basis to support local risk assessments and IPC recommendations.
Collapse
Affiliation(s)
- Axel Kramer
- Institute of Hygiene
and Environmental Medicine, University Medicine
Greifswald, Greifswald,
Germany
| | - Franziska Lexow
- Department for
Infectious Diseases, Unit 14: Hospital Hygiene, Infection Prevention and
Control, Robert Koch Institute,
Berlin, Germany
| | - Anna Bludau
- Department of
Infection Control and Infectious Diseases, University Medical Center
Göttingen (UMG), Georg-August University
Göttingen,
Göttingen, Germany
| | - Antonia Milena Köster
- Department of
Infection Control and Infectious Diseases, University Medical Center
Göttingen (UMG), Georg-August University
Göttingen,
Göttingen, Germany
| | - Martin Misailovski
- Department of
Infection Control and Infectious Diseases, University Medical Center
Göttingen (UMG), Georg-August University
Göttingen,
Göttingen, Germany
- Department of
Geriatrics, University of Göttingen Medical
Center, Göttingen,
Germany
| | - Ulrike Seifert
- Friedrich
Loeffler-Institute of Medical Microbiology – Virology, University
Medicine Greifswald,
Greifswald, Germany
| | - Maren Eggers
- Labor Prof. Dr. G.
Enders MVZ GbR, Stuttgart,
Germany
| | - William Rutala
- Division of Infectious
Diseases, University of North Carolina School of
Medicine, Chapel Hill,
North Carolina, USA
| | - Stephanie J. Dancer
- Department of
Microbiology, University Hospital
Hairmyres, Glasgow,
United Kingdom
- School of Applied
Sciences, Edinburgh Napier University,
Edinburgh, United Kingdom
| | - Simone Scheithauer
- Department of
Infection Control and Infectious Diseases, University Medical Center
Göttingen (UMG), Georg-August University
Göttingen,
Göttingen, Germany
| |
Collapse
|
10
|
Denkel LA, Voss A, Caselli E, Dancer SJ, Leistner R, Gastmeier P, Widmer AF. Can probiotics trigger a paradigm shift for cleaning healthcare environments? A narrative review. Antimicrob Resist Infect Control 2024; 13:119. [PMID: 39380032 PMCID: PMC11462747 DOI: 10.1186/s13756-024-01474-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2024] [Accepted: 09/25/2024] [Indexed: 10/10/2024] Open
Abstract
BACKGROUND The environment of healthcare institutions plays a major role in the transmission of multidrug resistant organisms (MDRO) and likely in subsequent healthcare-associated infections (HAIs). Probiotic cleaning products are a novel option for environmental cleaning. They represent a sustainable and biodegradable alternative to conventional chemical disinfectants for controlling microbial bioburden, and preventing pathogen transmission in hospital environments. High-quality studies including randomized clinical trials (RCT) triggered a summary with expert recommendations until further studies allow a critical review and meta-analysis of the data. METHODS Infection control experts from five European countries summarized available data as of June 2023. Authors presented their published RCTs, reviewed the existing literature on probiotic cleaning, summarized the results and identified knowledge gaps and subsequent research needs. RESULTS Probiotic cleaning was similarly effective for reducing HAI-related pathogens, enveloped viruses such as SARS-CoV-2 and MDRO in environmental samples compared to conventional chemical disinfectants. More importantly, probiotic cleaning was non-inferior to disinfectants in terms of preventing HAI in a large RCT. In addition, probiotic cleaning has also been shown to reduce antimicrobial resistance genes (ARG), costs and antimicrobial consumption in other hospital trials. They are biodegradable, do not require any protection for chemical hazards, and are compliant with occupational health. A paradigm shift, however, requires a very strong evidence to justify for such a change. In the past, this evidence was limited by the heterogeneity of study design, products, protocols, and few studies on clinical outcomes used in the trials. Furthermore, the regulatory, safety, and quality aspects of probiotic cleaning products are not, yet, completely defined and require clearing by authorities. CONCLUSION To date, probiotic cleaning is a breakthrough technology and a biological alternative for chemical disinfectant when treating hospital environment. It may also have a positive effect on MDRO transmission. However, the different compositions of probiotic products will require standardization, and more robust data should be generated to support these promising results on different compositions. This may trigger a paradigm shift in cleaning of healthcare institutions from chemical to biological control of the hospital environment.
Collapse
Affiliation(s)
- Luisa A Denkel
- Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Hindenburgdamm 27, 12203, Berlin, Germany.
- National Reference Center for the Surveillance of Nosocomial Infections, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
| | - Andreas Voss
- Department of Medical Microbiology and Infection Control, University Medical Center Groningen, Groningen, The Netherlands
| | - Elisabetta Caselli
- Section of Microbiology, Department of Chemical, Pharmaceutical, and Agricultural Sciences, University of Ferrara, Ferrara, Italy
| | | | - Rasmus Leistner
- Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Hindenburgdamm 27, 12203, Berlin, Germany
- National Reference Center for the Surveillance of Nosocomial Infections, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany
- Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany
| | - Petra Gastmeier
- Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Hindenburgdamm 27, 12203, Berlin, Germany
- National Reference Center for the Surveillance of Nosocomial Infections, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany
| | - Andreas F Widmer
- Faculty of Medicine, University of Basel, Basel, Switzerland
- Swissnoso - Swiss National Center for Infection Prevention, Bern, Switzerland
| |
Collapse
|
11
|
Golfiroozi S, Fashayi F, Rajabi A, Shahryar A. Disinfectants efficacy in reducing pathogens related to health-care infection associated in universities hospitals of Gorgan, North of Iran. BMC Infect Dis 2024; 24:1113. [PMID: 39375625 PMCID: PMC11457403 DOI: 10.1186/s12879-024-09985-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2024] [Accepted: 09/23/2024] [Indexed: 10/09/2024] Open
Abstract
BACKGROUND Disinfection has a fundamental role in the control of pathogens in the hospital environment. This study was designed to assess the efficacy and functional impact of disinfectants in reducing pathogens related to healthcare associated infections (HAIs) in hospitals. METHODS This observation study was conducted at three university hospitals in Gorgan, Iran, from May to Oct 2023. The data including used disinfectants and microbiological examination were obtained from the infection control unit of each hospital. RESULTS The results showed that a variety of disinfectants from intermediate to high levels were employed in accordance with the World Health Organization (WHO) protocols. The microbial result revealed that 31.6% (286 out of 906) of the sample had at least one microorganism. Among identified organisms, Bacillus spp. were the predominant species followed by Staphylococcus epidermis, fungus genera, Enterobacter spp., Enterococcus spp., Pseudomonas spp., Escherichia coli, Alcaligenes spp., Staphylococcus aureus, Citrobacter spp., Corynebacterium spp., Klebsiella spp., Acinetobacter spp., Micrococcus spp., Staphylococcus saprophyticus, and Serratias spp. The highest prevalence rates of microorganisms were observed in the wards of ICU, emergency, internal medicine, and women's ward. The chi-square test revealed a significant relationship between the presence of organisms and hospital wards (P < 0.05). CONCLUSION The presence of pathogens indicates a defect in the disinfection process, probably due to both little attention to disinfection protocols and multidrug resistance. It is not yet possible to eliminate pathogens from the hospital environment, but it can be minimized by education intervention, standardizing disinfecting processes, and monitoring by the infection control committee.
Collapse
Affiliation(s)
- Saeed Golfiroozi
- Department of Emergency Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
| | - Fateme Fashayi
- Student Research Committee, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
| | - Abdolhalim Rajabi
- Department of Biostatistics and Epidemiology, School of Health, Golestan University of Medical Sciences, Gorgan, Iran
| | - Ali Shahryar
- Environmental Health research center, Department of environmental Health,School of Health, Golestan University of Medical Sciences, Gorgan, Iran.
| |
Collapse
|
12
|
D'Accolti M, Soffritti I, Bini F, Mazziga E, Caselli E. Tackling transmission of infectious diseases: A probiotic-based system as a remedy for the spread of pathogenic and resistant microbes. Microb Biotechnol 2024; 17:e14529. [PMID: 39045894 PMCID: PMC11267305 DOI: 10.1111/1751-7915.14529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2024] [Accepted: 07/04/2024] [Indexed: 07/25/2024] Open
Abstract
Built environments (BEs) currently represent the areas in which human beings spend most of their life. Consistently, microbes populating BEs mostly derive from human occupants and can be easily transferred from BE to occupants. The hospital microbiome is a paradigmatic example, representing a reservoir for harmful pathogens that can be transmitted to susceptible patients, causing the healthcare-associated infections (HAIs). Environmental cleaning is a crucial pillar in controlling BE pathogens and preventing related infections, and chemical disinfectants have been largely used so far towards this aim. However, despite their immediate effect, chemical-based disinfection is unable to prevent recontamination, has a high environmental impact, and can select/increase antimicrobial resistance (AMR) in treated microbes. To overcome these limitations, probiotic-based sanitation (PBS) strategies were recently proposed, built on the use of detergents added with selected probiotics able to displace surrounding pathogens by competitive exclusion. PBS was reported as an effective and low-impact alternative to chemical disinfection, providing stable rebalance of the BE microbiome and significantly reducing pathogens and HAIs compared to disinfectants, without exacerbating AMR and pollution concerns. This minireview summarizes the most significant results obtained by applying PBS in sanitary and non-sanitary settings, which overall suggest that PBS may effectively tackle the infectious risk meanwhile preventing the further spread of pathogenic and resistant microbes.
Collapse
Affiliation(s)
- Maria D'Accolti
- Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTAUniversity of FerraraFerraraItaly
- CIAS Research CenterUniversity of FerraraFerraraItaly
| | - Irene Soffritti
- Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTAUniversity of FerraraFerraraItaly
- CIAS Research CenterUniversity of FerraraFerraraItaly
| | - Francesca Bini
- Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTAUniversity of FerraraFerraraItaly
- CIAS Research CenterUniversity of FerraraFerraraItaly
| | - Eleonora Mazziga
- Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTAUniversity of FerraraFerraraItaly
- CIAS Research CenterUniversity of FerraraFerraraItaly
| | - Elisabetta Caselli
- Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTAUniversity of FerraraFerraraItaly
- CIAS Research CenterUniversity of FerraraFerraraItaly
| |
Collapse
|
13
|
Fijan S, Kürti P, Rozman U, Šostar Turk S. A critical assessment of microbial-based antimicrobial sanitizing of inanimate surfaces in healthcare settings. Front Microbiol 2024; 15:1412269. [PMID: 38933019 PMCID: PMC11199901 DOI: 10.3389/fmicb.2024.1412269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2024] [Accepted: 05/22/2024] [Indexed: 06/28/2024] Open
Abstract
The global rise in antimicrobial resistance (AMR) poses a significant public health threat, especially in healthcare settings, where controlling the spread of antimicrobial genes is crucial. While person-to-person transmission remains the primary route for healthcare-associated infections (HAIs), hospital surfaces serve as key reservoirs for antimicrobial-resistant microorganisms. Regular cleaning and disinfection of these surfaces are essential. Microbial-based products for sanitizing hospital surfaces have emerged as promising tools to combat HAIs and AMR. However, a review of 32 publications found inconsistencies and potential risks. A total of 15 publications included hospital-based trials, while the rest were either in vitro or in situ assays, reviews, book chapters, or commentaries. In most of the hospital-based studies, specific strains of applied microorganisms were not identified, and the term "probiotic" was inaccurately used. These products mainly featured spores from Bacillus and Priestia genera, which was mainly hypothesized to work through competitive exclusion. Most hospital-based studies have shown that the application of microbial-based products resulted in a significant reduction in pathogens on surfaces, thereby contributing to a decrease in the incidence of healthcare-associated infections (HAIs). Further research is however needed to understand the effectiveness, mechanisms of action, and safety of microbial-based sanitizing agents. Strain-level identification is crucial for safety assessments, yet many reviewed products lacked this information. Consequently, there is a need for rigorous safety evaluations within existing regulatory frameworks to ensure the efficacy and safety of microbial-based cleaning products in healthcare settings.
Collapse
Affiliation(s)
- Sabina Fijan
- Faculty of Health Sciences, University of Maribor, Maribor, Slovenia
| | | | - Urška Rozman
- Faculty of Health Sciences, University of Maribor, Maribor, Slovenia
| | - Sonja Šostar Turk
- Faculty of Health Sciences, University of Maribor, Maribor, Slovenia
| |
Collapse
|
14
|
Guerrieri F, Libert C. The invisible life. Front Microbiol 2024; 15:1401487. [PMID: 38832115 PMCID: PMC11144902 DOI: 10.3389/fmicb.2024.1401487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2024] [Accepted: 04/29/2024] [Indexed: 06/05/2024] Open
Affiliation(s)
- Francesca Guerrieri
- Cancer Research Center of Lyon (CRCL), UMR Inserm 1052 - CNRS 5286, Lyon, France
| | - Cédric Libert
- Ecole Nationale Superieure d'Architecture de Saint-Etienne, Saint-Etienne, France
| |
Collapse
|
15
|
Hourigan D, Stefanovic E, Hill C, Ross RP. Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategy. BMC Microbiol 2024; 24:103. [PMID: 38539119 PMCID: PMC10976773 DOI: 10.1186/s12866-024-03243-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 02/28/2024] [Indexed: 04/19/2024] Open
Abstract
Vancomycin-resistant enterococci (VRE) are major opportunistic pathogens and the causative agents of serious diseases, such as urinary tract infections and endocarditis. VRE strains mainly include species of Enterococcus faecium and E. faecalis which can colonise the gastrointestinal tract (GIT) of patients and, following growth and persistence in the gut, can transfer to blood resulting in systemic dissemination in the body. Advancements in genomics have revealed that hospital-associated VRE strains are characterised by increased numbers of mobile genetic elements, higher numbers of antibiotic resistance genes and often lack active CRISPR-Cas systems. Additionally, comparative genomics have increased our understanding of dissemination routes among patients and healthcare workers. Since the efficiency of currently available antibiotics is rapidly declining, new measures to control infection and dissemination of these persistent pathogens are urgently needed. These approaches include combinatory administration of antibiotics, strengthening colonisation resistance of the gut microbiota to reduce VRE proliferation through commensals or probiotic bacteria, or switching to non-antibiotic bacterial killers, such as bacteriophages or bacteriocins. In this review, we discuss the current knowledge of the genomics of VRE isolates and state-of-the-art therapeutic advances against VRE infections.
Collapse
Affiliation(s)
- David Hourigan
- APC Microbiome Ireland, Biosciences Institute, Biosciences Research Institute, College Rd, University College, Cork, Ireland
- School of Microbiology, University College Cork, College Rd, University College, Cork, Ireland
| | - Ewelina Stefanovic
- APC Microbiome Ireland, Biosciences Institute, Biosciences Research Institute, College Rd, University College, Cork, Ireland
- Teagasc Food Research Centre, Moorepark, Moorepark West, Fermoy, Co. Cork, Ireland
| | - Colin Hill
- APC Microbiome Ireland, Biosciences Institute, Biosciences Research Institute, College Rd, University College, Cork, Ireland
- School of Microbiology, University College Cork, College Rd, University College, Cork, Ireland
| | - R Paul Ross
- APC Microbiome Ireland, Biosciences Institute, Biosciences Research Institute, College Rd, University College, Cork, Ireland.
- School of Microbiology, University College Cork, College Rd, University College, Cork, Ireland.
- Teagasc Food Research Centre, Moorepark, Moorepark West, Fermoy, Co. Cork, Ireland.
| |
Collapse
|